WARFARIN TIME IN THERAPEUTIC RANGE TRAJECTORIES IN POTENTIAL SWITCHERS TO DIRECT ORAL ANTICOAGULANTS

Of contemporary warfarin treated atrial fibrillation (AF) patients eligible for direct oral anticoagulants (DOAC), many remain on warfarin. However, expected INR time in therapeutic range (TTR) of potential switchers has not been characterized. We performed a retrospective cohort study of patients